GTBP ▼ -1.9% - GT Biopharma, Inc.
$GTBP - GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
GT Biopharma fell 1.9% today ahead of a scheduled company presentation on its TriKE® Platform for cancer treatment set for September 11, 2026. The decline occurred despite the announcement of the upcoming investor event, which will focus on the company's development progress in this therapeutic approach.
11-SEP-2026 08:00 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
